MOZARC MEDICAL
DEAD

Serial Number

97569548

Owner

MEDTRONIC, INC.

Attorney

Roger Hahn

Filing Date

Aug 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

MOZARC MEDICAL Trademark

Serial Number: 97569548

MOZARC MEDICAL is a trademark filed by MEDTRONIC, INC. on August 29, 2022. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

MEDTRONIC, INC. (1,731 trademarks)

MINNEAPOLIS, MN 55418

Entity Type: 03

MOZARC MEDICAL US LLC (19 trademarks)

710 MEDTRONIC PARKWAY
MINNEAPOLIS, MN 55431

Entity Type: 16

Trademark Details

Filing Date

August 29, 2022

Registration Date

Not Registered

Goods & Services

Computer, processors, and mobile device software, algorithms, and methods used to manage, control, operate and display information from medical devices for the treatment of organ deficiencies, medical devices for renal and extra-renal therapies, medical devices for filtration of bodily fluids and plasma exchanges, dialysis machines, and blood filtering devices; machine learning both supervised and unsupervised for managing kidney prescriptions and monitoring same; cloud infrastructure and related management software to manage patient prescriptions and ordering of consumables, kits, service, and maintenance of equipment

Pharmaceutical solutions used in dialysis; fluids for peritoneal or parenteral administration including dextrose in water, dextrose and sodium chloride in water, dextrose and vitamins, dextrose and any combination of sodium chloride, magnesium chloride, calcium chloride, and sodium lactate; dialysis solutions containing vitamins, water, protein, osmotic agents; sterile, non-pyrogenic fluids for use in solutions to be administered parenterally; sugars in water; fluids for use in dialysis containing any amount of icodextrin or polyglucose; medical preparations for use in dialysis containing pharmaceuticals

Dialysis machines; medical instruments and apparatus for purification and filtration of blood; medical apparatus and instruments for the treatment of kidney failure; dialysis equipment and parts therefor, including dialysis machines, consoles, sorbent rechargers, dialyzers, filters, and sorbent cartridges; kidney dialysis equipment for peritoneal dialysis, hemodialysis, hemodiafiltration, ultrafiltration, and accessories therefor for use in a home or clinical setting, namely, dialysis machines and disposables for use in dialysis machines, cassettes, tubing sets, tubing and empty containers; computerized electrolyte analyzers; blood cell separating machines, components, and fiber; tubing systems, blood lines, needles, valves, lock caps, valves, catheters, catheter adapters, clamps, cones for dialysis machines; containers for solutions used for the treatment of kidney disease, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use; dialyzers; blood filtration; plasma filtrations components and fibers for making same; medical devices and apparatus used to filter fluids and wastes from a patient's blood; filters for blood and blood components for medical purposes; medical instruments for use in dialysis; catheters and parts and fittings therefor; and tubing for use with catheters; dialyzers; electronic identification apparatus and instruments for dialysis equipment, namely, Radio Frequency Identification and Distribution (RFID) apparatus and instruments, namely, transceivers, transmitters, receivers, readers, antennas and reader management equipment, RFID transponders, RFID tags and RFID evaluation kits comprised of RFID readers and antennas for dialysis equipment, consumables, and kits

Filing History

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 3, 2023 ASGN
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 27, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Mar 25, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 25, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 7, 2022 CNRT
ASSIGNED TO EXAMINER
Nov 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 15, 2022 NWOS
NEW APPLICATION ENTERED
Sep 1, 2022 NWAP